Antidotes for factor Xa inhibitors and methods of using the same

Details for Australian Patent Application No. 2008304192 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Phillips, David R.; Andre, Patrick; Sinha, Uma; Lu, Genmin

Agent Freehills

Pub. Number AU-A-2008304192

PCT Pub. Number WO2009/042962

Priority 61/090,574 20.08.08 US; 60/976,343 28.09.07 US

Filing date 26 September 2008

Wipo publication date 2 April 2009

International Classifications

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61K 31/4545 (2006.01)

A61K 31/5377 (2006.01)

A61K 31/715 (2006.01) - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages

A61K 31/727 (2006.01)

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/042962 Priority application(s): WO2009/042962

8 April 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 10 Mar 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008304198-Sustained release dosage forms for delivery of agents to an oral cavity of a user

2008304187-Methods, devices, systems, assemblies, and kits for tissue retraction in an oral cavity